Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1941 2
1942 1
1945 2
1946 1
1947 1
1948 2
1955 1
1964 2
1982 1
1983 1
1987 1
1989 4
1990 5
1991 5
1992 5
1993 3
1994 2
1995 5
1996 4
1997 5
1998 1
1999 4
2000 7
2001 4
2002 3
2003 6
2004 9
2005 12
2006 9
2007 9
2008 9
2009 11
2010 16
2011 19
2012 17
2013 21
2014 22
2015 27
2016 31
2017 18
2018 27
2019 18
2020 27
2021 36
2022 21
2023 22
2024 33
2025 26
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Results by year

Filters applied: . Clear all
Page 1
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, Thomas CR Jr, Alberts SR, Dawson LA, Micetich KC, Thomas MB, Siegel AB, Blanke CD. Ben-Josef E, et al. Among authors: guthrie ka. J Clin Oncol. 2015 Aug 20;33(24):2617-22. doi: 10.1200/JCO.2014.60.2219. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964250 Free PMC article. Clinical Trial.
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Meyerhardt JA, Shi Q, Fuchs CS, Meyer J, Niedzwiecki D, Zemla T, Kumthekar P, Guthrie KA, Couture F, Kuebler P, Bendell JC, Kumar P, Lewis D, Tan B, Bertagnolli M, Grothey A, Hochster HS, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF. Meyerhardt JA, et al. Among authors: guthrie ka. JAMA. 2021 Apr 6;325(13):1277-1286. doi: 10.1001/jama.2021.2454. JAMA. 2021. PMID: 33821899 Free PMC article. Clinical Trial.
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).
Kopetz S, Guthrie KA, Morris VK, Lenz HJ, Magliocco AM, Maru D, Yan Y, Lanman R, Manyam G, Hong DS, Sorokin A, Atreya CE, Diaz LA, Allegra C, Raghav KP, Wang SE, Lieu CH, McDonough SL, Philip PA, Hochster HS. Kopetz S, et al. Among authors: guthrie ka. J Clin Oncol. 2021 Feb 1;39(4):285-294. doi: 10.1200/JCO.20.01994. Epub 2020 Dec 23. J Clin Oncol. 2021. PMID: 33356422 Free PMC article. Clinical Trial.
To the Editor.
Mitchell CM, Reed SD, Diem S, Ensrud KE, LaCroix AZ, Newton KM, Guthrie KA. Mitchell CM, et al. Among authors: guthrie ka. Menopause. 2020 Jul;27(7):836-837. doi: 10.1097/GME.0000000000001606. Menopause. 2020. PMID: 32604325 No abstract available.
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.
Shroff RT, King G, Colby S, Scott AJ, Borad MJ, Goff L, Matin K, Mahipal A, Kalyan A, Javle MM, El Dika I, Tan B, Cheema P, Patel A, Iyer R, Kelley RK, Thumar J, El-Khoueiry A, Guthrie KA, Chiorean EG, Hochster H, Philip PA. Shroff RT, et al. Among authors: guthrie ka. J Clin Oncol. 2025 Feb 10;43(5):536-544. doi: 10.1200/JCO-24-01383. Epub 2024 Dec 13. J Clin Oncol. 2025. PMID: 39671534 Free PMC article. Clinical Trial.
Leadership education through complex transitions.
Chung J, Gleason M, Guthrie KL, Navarro CD, Priest KL, Pierre DE, Steele MC, Weng J. Chung J, et al. Among authors: guthrie kl. New Dir Stud Leadersh. 2021 Dec;2021(172):5-10. doi: 10.1002/yd.20463. New Dir Stud Leadersh. 2021. PMID: 35061315 No abstract available.
Series Editors' Notes.
Komives SR, Guthrie KL. Komives SR, et al. Among authors: guthrie kl. New Dir Stud Leadersh. 2015 Spring;2015(145):1-3. doi: 10.1002/yd.20118. New Dir Stud Leadersh. 2015. PMID: 26894785 No abstract available.
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.
Raghav KPS, Guthrie KA, Tan B Jr, Denlinger CS, Fakih M, Overman MJ, Dasari NA, Corum LR, Hicks LG, Patel MS, Esparaz BT, Kazmi SM, Alluri N, Colby S, Gholami S, Gold PJ, Chiorean EG, Kopetz S, Hochster HS, Philip PA. Raghav KPS, et al. Among authors: guthrie ka. J Clin Oncol. 2025 Apr 10;43(11):1348-1357. doi: 10.1200/JCO-24-01710. Epub 2025 Jan 6. J Clin Oncol. 2025. PMID: 39761503 Clinical Trial.
Forging new directions.
Guthrie KL, Chunoo VS. Guthrie KL, et al. New Dir Stud Leadersh. 2024 Jun;2024(182):5-9. doi: 10.1002/yd.20597. Epub 2024 May 14. New Dir Stud Leadersh. 2024. PMID: 38742578 No abstract available.
457 results